Bluejay Diagnostics

United States
Montezuma, Iowa, United States, 01720

Company profile

Bluejay Diagnostics company profile

Bluejay Diagnostics, Inc. develops, manufactures and markets easy-to-use, point-of-care medical diagnostics tests. The company offers multiple FDA-Cleared non-invasive, affordable products, including the Allereye® Tear Total IgE Test used to aid in the diagnosis of allergic conjunctivitis, and a urine-based HIV-1 screening test and a HIV-1 confirmatory test. Bluejay, headquartered in Acton, Massachusetts, continues to leverage its innovate, proprietary platform to develop new products for underserved diagnostic markets.

Business identity

Contact email
[email protected]
Phone number
978.631.4884
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
01720
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
7
Total equity funding
$24.9M
Last funding
Post IPO Equity / $4.5M / 2025-10-09
Last equity funding
Post IPO Equity / $4.5M
Investors
1
Founders
2
Articles
61
Exited on
2021-11-12

Founders and investors

Founders

Indranil DeySvetlana Dey

Investors

Centrecourt Asset Management